- Exhibit & Support
- Travel & Hotels
New and emerging insulin products not only expand therapeutic options but also complicate treatment decisions for parents, prescribers, and pharmacists. Newer agents include insulin glargine U300, regular insulin U500, and insulin degludec U-100 and U-200. In this interactive case-based session, experts will facilitate a discussion about the safe and effective use of new insulin products including strategies to titrate insulin doses, methods to safely switch insulin products, and practical advice to minimize hypoglycemia.
At the completion of this application-based activity, participants will be able to: